Overview
Dr. Noreen Hynes has over 35 years of medical and public health experience in both international and domestic settings. Her career has encompassed basic and applied research, epidemiology, public health, clinical medicine, and the regulatory aspects of medical countermeasures for emerging and infectious diseases and high-consequence pathogens. Dr. Hynes has been affiliated with The Johns Hopkins Medical Institutions and the Schools of Medicine and Public Health University since 1997. She is currently an Associate Professor of Medicine (part-time) in the School of Medicine, Division of Infectious Diseases, and is jointly appointed in the School of Public Health in the Department of International Health. Since 2009, Dr. Hynes has served as the director of the Geographic Medicine Center in the Division of Infectious Diseases in the Johns Hopkins School of Medicine, as the Medical Director of the Johns Hopkins Tropical & Travel Medicine Service, and as the Baltimore Site Director for the CDC-sponsored GeoSentinel Surveillance System. Dr. Hynes serves as the Director of Research and the Associate Medical Director of the Johns Hopkins Hospital BioContainment Unit. She also serves as the co-director of the Infectious Disease concentration in the Johns Hopkins Master of Public Health degree program. Dr. Hynes' research interests focus on infectious diseases at the clinical-public health interface in resource-constrained settings in both tropical and temperate regions. Her research focuses on tropical diseases, including those that or zoonoses or high-consequence pathogens. Her research focuses on these pathogens including examining deliberate and naturally-occurring exposures/outcomes, the epidemiology and control of emerging infectious diseases, and collaboration on vaccine clinical trials conducted by the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health.
Dr. Hynes is rated as an Experienced provider by MediFind in the treatment of Dengue Fever. Her top areas of expertise are Viral Hemorrhagic Fever, Ebola Virus Disease, Dengue Fever, and COVID-19.
Her clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Dengue Fever.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
615 North Wolfe Street, WB031, Wb031, Baltimore, MD 21205
615 North Wolfe Street, Wb031, Baltimore, MD 21205
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is rated as a Distinguished provider by MediFind in the treatment of Dengue Fever. Her top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever.
University Of Maryland Physicians PA
Joel Chua is an Infectious Disease provider in Baltimore, Maryland. Dr. Chua is rated as an Advanced provider by MediFind in the treatment of Dengue Fever. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Hepatitis, and Osteomyelitis.
University Of Maryland Physicians PA
Kirsten Lyke is an Infectious Disease provider in Baltimore, Maryland. Dr. Lyke is rated as a Distinguished provider by MediFind in the treatment of Dengue Fever. Her top areas of expertise are Malaria, Primary Amebic Meningoencephalitis, Rabies, and Viral Hemorrhagic Fever.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Dr. Hynes isExperienced. Learn about COVID-19.
- Dengue FeverDr. Hynes isExperienced. Learn about Dengue Fever.
- Ebola Virus DiseaseDr. Hynes isExperienced. Learn about Ebola Virus Disease.
- Parainfluenza Virus Type 3Dr. Hynes isExperienced. Learn about Parainfluenza Virus Type 3.
- RabiesDr. Hynes isExperienced. Learn about Rabies.
- SepsisDr. Hynes isExperienced. Learn about Sepsis.